Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study Program to Investigate the Effectiveness of Intravitreal Aflibercept in Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion in a Real World Setting

NCT03161912 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03161912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03161912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study Program to Investigate the Effectiveness of Intravitreal Aflibercept in Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion in a Real World Setting
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
November 24, 2017
Completion date
December 17, 2021
Enrollment
2,481 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema